Milliman Funds Trust. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| BondBloxx Bloomberg Five Year | 35.29% | $348.60K | 7,161 |
| TREASURY BILLBond | 27.61% | $272.75K | 273,300 |
| BondBloxx Bloomberg Six Month | 14.34% | $141.70K | 2,817 |
| State Street SPDR S&P 500 ETFSPY | 3.40% | $33.60K | 45 |
| Eli Lilly & CoLLY | 1.70% | $16.79K | 14 |
| UnitedHealth Group IncUNH | 1.47% | $14.55K | 35 |
| SPDR Gold SharesDerivative | 1.06% | $10.52K | 8 |
| Johnson & JohnsonJNJ | 1.03% | $10.16K | 40 |
| Thermo Fisher Scientific IncTMO | 1.02% | $10.03K | 20 |
| Abbott LaboratoriesABT | 0.85% | $8.35K | 92 |
| Intuitive Surgical IncISRG | 0.76% | $7.56K | 19 |
| Danaher CorpDHR | 0.73% | $7.24K | 38 |
| Stryker CorpSYK | 0.64% | $6.30K | 20 |
| Merck & Co IncMRK | 0.61% | $6.04K | 47 |
| Medtronic PLC | 0.55% | $5.40K | 69 |
| CVS Health CorpCVS | 0.50% | $4.97K | 48 |
| AbbVie IncABBV | 0.43% | $4.28K | 17 |
| McKesson CorpMCK | 0.38% | $3.78K | 5 |
| Boston Scientific CorpBSX | 0.36% | $3.54K | 83 |
| HCA Healthcare IncHCA | 0.36% | $3.51K | 9 |
| Bristol-Myers Squibb CoBMY | 0.33% | $3.23K | 56 |
| Elevance Health IncELV | 0.31% | $3.09K | 8 |
| Cigna Group/TheCI | 0.28% | $2.76K | 10 |
| Edwards Lifesciences CorpEW | 0.27% | $2.71K | 30 |
| Becton Dickinson & CoBDX | 0.23% | $2.27K | 15 |
| Cencora IncCOR | 0.23% | $2.26K | 8 |
| Cardinal Health IncCAH | 0.22% | $2.14K | 9 |
| IDEXX Laboratories IncIDXX | 0.21% | $2.11K | 4 |
| Agilent Technologies IncA | 0.20% | $1.99K | 15 |
| Humana IncHUM | 0.20% | $1.99K | 5 |
| Natera IncNTRA | 0.19% | $1.90K | 7 |
| Medline IncMDLN | 0.19% | $1.89K | 48 |
| Waters CorpWAT | 0.19% | $1.88K | 5 |
| IQVIA Holdings IncIQV | 0.18% | $1.74K | 9 |
| Revolution Medicines IncRVMD | 0.17% | $1.69K | 9 |
| GE HealthCare Technologies IncGEHC | 0.17% | $1.66K | 26 |
| United Therapeutics CorpUTHR | 0.16% | $1.63K | 3 |
| Madrigal Pharmaceuticals IncMDGL | 0.16% | $1.61K | 3 |
| Veeva Systems IncVEEV | 0.16% | $1.60K | 9 |
| ResMed IncRMD | 0.16% | $1.56K | 8 |
| Dexcom IncDXCM | 0.15% | $1.48K | 22 |
| Moderna IncMRNA | 0.15% | $1.47K | 21 |
| West Pharmaceutical Services IWST | 0.15% | $1.44K | 4 |
| Illumina IncILMN | 0.14% | $1.41K | 8 |
| Labcorp Holdings IncLH | 0.14% | $1.40K | 5 |
| Mettler-Toledo International IMTD | 0.13% | $1.28K | 1 |
| Quest Diagnostics IncDGX | 0.13% | $1.27K | 6 |
| U.S. Bank Money Market Deposit AccountCash or money market | 0.12% | $1.23K | 1,234 |
| Centene CorpCNC | 0.12% | $1.22K | 19 |
| Neurocrine Biosciences IncNBIX | 0.12% | $1.18K | 7 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.